Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2063 publications

Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis.

Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis.

Journal: Archives of rheumatology
Published: September 22, 2025

Pulmonary alveolar proteinosis with atypical clinical and bronchoscopic features.

Pulmonary alveolar proteinosis with atypical clinical and bronchoscopic features.

Journal: BMJ case reports
Published: September 18, 2025

Ramosetron as a Supportive Agent to Continue Nintedanib in Patients with Interstitial Lung Disease.

Ramosetron as a Supportive Agent to Continue Nintedanib in Patients with Interstitial Lung Disease.

Journal: Internal medicine (Tokyo, Japan)
Published: September 10, 2025

The Role of Antifibrotic Therapy in Pulmonary Fibrosis and Lung Cancer: A Multicenter Retrospective Analysis.

The Role of Antifibrotic Therapy in Pulmonary Fibrosis and Lung Cancer: A Multicenter Retrospective Analysis.

Journal: Biomedicines
Published: August 23, 2025

Lung and systemic sclerosis

Lung and systemic sclerosis

Journal: La Revue de medecine interne
Published: August 18, 2025

p53-miR-34a Feedback in Lung Fibroblasts Regulates Antifibrotic Effects of CSP7, Nintedanib and Pirfenidone.

p53-miR-34a Feedback in Lung Fibroblasts Regulates Antifibrotic Effects of CSP7, Nintedanib and Pirfenidone.

Journal: American journal of physiology. Lung cellular and molecular physiology
Published: August 18, 2025

The fibrosis puzzle of systemic sclerosis-associated ILD and the quest for targeted interventions.

The fibrosis puzzle of systemic sclerosis-associated ILD and the quest for targeted interventions.

Journal: Therapeutic advances in respiratory disease
Published: August 16, 2025

Constructive Critique on "Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis from a Multicenter Observational Study in Kyushu and Okinawa, Japan".

Constructive Critique on "Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis from a Multicenter Observational Study in Kyushu and Okinawa, Japan".

Journal: Clinical therapeutics
Published: August 13, 2025

From renal crisis to lung fibrosis - systemic sclerosis in the course of time

From renal crisis to lung fibrosis - systemic sclerosis in the course of time

Journal: Deutsche medizinische Wochenschrift (1946)
Published: August 05, 2025

Clinical efficacy and safety evaluation of drug therapies for the treatment of progressive fibrotic-interstitial lung diseases (PF-ILDs): a network meta-analysis of randomized controlled trials.

Clinical efficacy and safety evaluation of drug therapies for the treatment of progressive fibrotic-interstitial lung diseases (PF-ILDs): a network meta-analysis of randomized controlled trials.

Journal: Expert review of clinical immunology
Published: August 04, 2025

Quantification and Analysis of Lung Involvement by Artificial Intelligence in Patients with Progressive Pulmonary Fibrosis Treated with Nintedanib.

Quantification and Analysis of Lung Involvement by Artificial Intelligence in Patients with Progressive Pulmonary Fibrosis Treated with Nintedanib.

Journal: Medicina (Kaunas, Lithuania)
Published: August 01, 2025

Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice.

Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice.

Journal: Journal of clinical medicine
Published: July 27, 2025
Showing 1-12 of 2,063

Last Updated: 10/31/2025